543520 — Global Longlife Hospital and Research Income Statement
0.000.00%
- IN₹330.75m
- IN₹454.26m
- IN₹135.15m
Annual income statement for Global Longlife Hospital and Research, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 335 | 327 | 328 | 235 | 135 |
Cost of Revenue | |||||
Gross Profit | 285 | 241 | 156 | 100 | 50.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 323 | 285 | 259 | 206 | 151 |
Operating Profit | 12.3 | 41.8 | 69.4 | 28.7 | -15.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.6 | 18.2 | 57.1 | 27.1 | -22.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.62 | 10.4 | 35.7 | 18.3 | -21.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.62 | 10.4 | 35.7 | 18.3 | -21.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.62 | 10.4 | 35.7 | 18.3 | -21.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.23 | 1.48 | 5.16 | 1.79 | -2.08 |
Dividends per Share |